stockrow
Saturday 7 November 2026
Export LICN’s income statement to Excel — free account
Lichen International Limited
LICN Industrials Specialty Business Services
Lichen International Limited’s revenue for fiscal 2025 (year ended December 2025) was $24.5 million, down 40.9% from fiscal 2024.
0.51
0.08
−13.56%
Follow LICN
Alert me
| Dec '17 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | 6 | 7 | 5 | 3 | 2 |
Altman Z-Score |
— | — | — | — | — | 10.42 | 2.39 | 2.19 |
Altman Z″-Score (non-manufacturers) |
16.13 | 12.54 | 12.20 | 13.32 | 15.48 | 22.90 | 22.34 | 16.74 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | — | (2.33) | (2.00) | (2.77) | (1.47) | (2.17) | (2.98) |
P/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (1.38) | 18.16 | 1.23 |
EV/FCF |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (1.95) | 3.53 | 1.04 |
Quick Ratio |
2.26 | 1.44 | 2.02 | 3.47 | 5.00 | 7.41 | 7.25 | 6.23 |
Current Ratio |
3.31 | 1.47 | 2.04 | 3.91 | 5.21 | 9.81 | 7.96 | 7.73 |
Net Debt/EBITDA |
(0.51) | (0.43) | (0.75) | (1.20) | (1.70) | (1.71) | 14.86 | 1.92 |
Debt/Assets |
0.00% | 1.09% | 1.01% | 0.80% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 1.25 | 0.99 | 0.90 | 0.76 | 0.71 | 0.57 | 0.32 |
Operating CF/Net income |
0.98 | 1.92 | 1.30 | 0.86 | 1.38 | 0.07 | 0.91 | 0.81 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.23 | (1.09) | (1.86) | (0.01) | 0.00 |
Interest Coverage |
590.78 | 397.06 | 170.62 | — | — | — | — | — |
| 0.00% | 33.43% | 24.95% | 26.25% | 20.06% | 16.26% | (8.96%) | (30.06%) | |
| 0.00% | 27.92% | 20.62% | 22.18% | 17.48% | 14.88% | (8.45%) | (28.26%) | |
ROIC |
0.00% | 0.00% | 0.00% | 34.73% | 35.95% | 21.54% | (5.82%) | (25.88%) |
Return on Tangible Assets |
36.49% | 39.68% | 29.50% | 25.87% | 22.13% | 16.46% | (14.13%) | (57.00%) |
Average Days of Receivables |
34.06 | 21.72 | 33.72 | 46.41 | 38.28 | 40.97 | 37.51 | 33.64 |
Research and Development Expense of Revenue |
2.42% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
32.49% | 30.42% | 32.77% | 26.76% | 28.23% | 30.34% | 72.87% | 96.02% |
Intangible Assets out of Total Assets |
0.03 | 0.19 | 0.17 | 0.09 | 0.10 | 0.09 | 0.19 | 0.12 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 8.23% | 1.28% |
Graham Net Nets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Revenue per Share |
0.00 | 1.10 | 1.07 | 304.84 | 300.49 | 304.90 | 235.80 | 4.62 |
Operating CF per Share |
0.00 | 0.47 | 0.29 | 64.92 | 95.70 | 4.27 | (31.68) | (3.37) |
Capex per Share |
— | 0.00 | 0.00 | 4.99 | (25.26) | (40.39) | (0.20) | 0.00 |
Free Cash Flow per Share |
0.00 | 0.47 | 0.29 | 69.91 | 70.44 | (36.12) | (31.88) | (3.37) |
Cash per Share |
0.00 | 0.19 | 0.30 | 149.73 | 200.88 | 198.28 | 151.86 | 5.08 |
Shareholders Equity per Share |
0.00 | 0.83 | 0.96 | 327.40 | 365.41 | 471.01 | 429.59 | 13.31 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 0.83 | 0.96 | 327.40 | 365.41 | 471.01 | 429.59 | 13.31 |
Free Cash Flow |
6.36 | 13.57 | 8.35 | 7.87 | 7.92 | (4.71) | (5.61) | (17.85) |
Working Capital |
7.56 | 2.36 | 5.95 | 17.78 | 22.04 | 36.04 | 29.74 | 31.49 |
Capital Expenditures |
(4.46) | (10.83) | (1.16) | 0.56 | (2.84) | (5.27) | (0.04) | — |
Net Current Asset Value |
7.56 | 2.36 | 5.95 | 17.78 | 21.85 | 36.01 | 29.74 | 31.14 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | (0.02) | 0.08 | 0.13 | 0.00 | 0.00 |
| Other line items | ||||||||
Depreciation/Fixed assets |
0.04 | 0.14 | 0.14 | 0.16 | 0.20 | 0.19 | 0.20 | 0.57 |
Cash ROIC |
26.98% | 46.11% | 22.79% | 14.56% | 12.44% | (5.40%) | (5.48%) | (18.31%) |
Accounts Receivable Turnover |
0.00 | 14.81 | 13.01 | 9.53 | 8.55 | 9.93 | 9.51 | 7.52 |
Accounts Payable Turnover |
0.00 | 186.61 | 131.46 | 126.79 | 95.87 | 139.09 | 272.47 | 0.00 |
Inventory Turnover |
0.00 | 341.98 | 422.54 | 159.77 | 98.29 | 144.29 | 205.23 | 0.00 |
Average Days of Payables |
2.31 | 2.53 | 2.93 | 3.25 | 4.32 | 1.44 | 1.27 | 0.00 |
Days of Inventory on Hand |
1.92 | 0.98 | 0.71 | 3.96 | 3.41 | 2.06 | 1.55 | 0.00 |
Average Receivables |
— | 2.13 | 2.36 | 3.60 | 3.95 | 4.00 | 4.36 | 3.26 |
Average Payables |
— | 0.07 | 0.09 | 0.11 | 0.14 | 0.11 | 0.06 | — |
Average Inventory |
— | 0.04 | 0.03 | 0.09 | 0.14 | 0.11 | 0.08 | — |
Average Assets |
— | 25.32 | 31.07 | 38.15 | 44.73 | 56.04 | 72.69 | 77.71 |
Average Common Equity |
— | 21.15 | 25.68 | 32.24 | 38.97 | 51.26 | 68.49 | 73.06 |
Columns are period end dates · fundamentals updated 2 Nov 2026